<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01947335</url>
  </required_header>
  <id_info>
    <org_study_id>02358512.7.0000.0068</org_study_id>
    <nct_id>NCT01947335</nct_id>
  </id_info>
  <brief_title>IVUS Guidance to Reduce Contrast in Coronary Angioplasty</brief_title>
  <acronym>MOZART</acronym>
  <official_title>Minimizing cOntrast utiliZAtion With IVUS Guidance in coRonary angioplasTy: The MOZART Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>InCor Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>InCor Heart Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tests the hypothesis that ultrasound-guided PCI reduces contrast volume during the
      procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Contrast-induced acute kidney injury (CI-AKI) is an important adverse effect of percutaneous
      coronary interventions. Despite various efforts, very few preventive measures have been shown
      effective in reducing its incidence. The final volume of contrast media utilized during the
      procedure is a well-known independent factor affecting the occurrence of CI-AKI.

      Intravascular ultrasound (IVUS) has been largely used as an adjunctive diagnostic tool during
      percutaneous coronary intervention (PCI). When fully explored, IVUS provides precise
      information for guiding the PCI strategy. IVUS allows accurate vessel and lesion sizing,
      determination of plaque calcification (and the need for pre-stent plaque preparation),
      assessment of post-stent results (including edge dissections and residual lesion, as well as
      stent underexpansion or incomplete apposition). Therefore, IVUS has the potential to reduce
      the utilization of contrast media during PCI.

      In the present study, we hypothesize that IVUS guidance is associated with a significant
      reduction in the volume of contrast media during PCI, in comparison to standard
      angiography-guided intervention.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2012</start_date>
  <completion_date type="Actual">September 2013</completion_date>
  <primary_completion_date type="Actual">September 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Volume of Iodine Contrast Used During Procedure</measure>
    <time_frame>Day 1</time_frame>
    <description>Total volume of iodine contrast administered during the index procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Major Adverse Cardiac Events</measure>
    <time_frame>30 days and 6 months</time_frame>
    <description>Composite of death, myocardial infarction or repeat revascularization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Incidence of Contrast-induced Nephropathy</measure>
    <time_frame>7 days</time_frame>
    <description>Increase &gt;= 0.5 mg/dl in basal serum creatinine</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">83</enrollment>
  <condition>Contrast Media Reaction</condition>
  <condition>Acute Renal Failure</condition>
  <arm_group>
    <arm_group_label>Angiography-guided PCI</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Angiography-guided percutaneous coronary intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravascular ultrasound guided percutaneous coronary intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>IVUS-guided PCI</intervention_name>
    <description>Intravascular ultrasound guided percutaneous coronary intervention</description>
    <arm_group_label>IVUS-guided PCI</arm_group_label>
    <other_name>Intravascular ultrasound</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Written informed consent

          -  Age &gt;=18 years

          -  Coronary artery disease scheduled for percutaneous intervention

          -  Technical feasibility for intravascular ultrasound to guide coronary angioplasty

          -  Increased risk for contrast-induced acute renal failure (e.g. age &gt; 80 years, female
             gender, diabetes, urgent or emergent procedure priority, diabetes, congestive heart
             failure, increased baseline serum creatinine, decreased calculated or measured
             creatinine clearance, intra-aortic balloon pumping, previous renal transplantation or
             single kidney)

        Exclusion Criteria:

          -  Anticipated technical impossibility for intravascular ultrasound

          -  Unknown baseline renal function

          -  Baseline end-stage renal failure needing dialysis

          -  Acute renal failure with dynamic change in renal function at the time of index
             procedure

          -  Iodine contrast administration &lt;= 72 prior to index procedure

          -  Known allergy to iodine contrast
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pedro A Lemos, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Paulo R Soares, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Heart Institute - InCor. University of Sao Paulo Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Heart Institute - InCor. University of Sao Paulo Medical School</name>
      <address>
        <city>Sao Paulo</city>
        <zip>05403-000</zip>
        <country>Brazil</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 1, 2013</study_first_submitted>
  <study_first_submitted_qc>September 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 20, 2013</study_first_posted>
  <results_first_submitted>May 6, 2016</results_first_submitted>
  <results_first_submitted_qc>May 6, 2016</results_first_submitted_qc>
  <results_first_posted type="Estimate">June 15, 2016</results_first_posted>
  <last_update_submitted>May 6, 2016</last_update_submitted>
  <last_update_submitted_qc>May 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>InCor Heart Institute</investigator_affiliation>
    <investigator_full_name>Pedro A. Lemos</investigator_full_name>
    <investigator_title>Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Coronary</keyword>
  <keyword>Angioplasty</keyword>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Stent</keyword>
  <keyword>Contrast</keyword>
  <keyword>Acute Renal failure</keyword>
  <keyword>Intravascular ultrasound</keyword>
  <keyword>Prevention</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Acute Kidney Injury</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Angiography-guided PCI</title>
          <description>Angiography-guided percutaneous coronary intervention</description>
        </group>
        <group group_id="P2">
          <title>IVUS-guided PCI</title>
          <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="42"/>
                <participants group_id="P2" count="41"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Angiography-guided PCI</title>
          <description>Angiography-guided percutaneous coronary intervention</description>
        </group>
        <group group_id="B2">
          <title>IVUS-guided PCI</title>
          <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="42"/>
            <count group_id="B2" value="41"/>
            <count group_id="B3" value="83"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="62.1" lower_limit="57.3" upper_limit="76.5"/>
                    <measurement group_id="B2" value="67.1" lower_limit="58.3" upper_limit="76.1"/>
                    <measurement group_id="B3" value="64.6" lower_limit="57.3" upper_limit="76.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="17"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Brazil</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="42"/>
                    <measurement group_id="B2" value="41"/>
                    <measurement group_id="B3" value="83"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Volume of Iodine Contrast Used During Procedure</title>
        <description>Total volume of iodine contrast administered during the index procedure.</description>
        <time_frame>Day 1</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Angiography-guided PCI</title>
            <description>Angiography-guided percutaneous coronary intervention</description>
          </group>
          <group group_id="O2">
            <title>IVUS-guided PCI</title>
            <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Total Volume of Iodine Contrast Used During Procedure</title>
          <description>Total volume of iodine contrast administered during the index procedure.</description>
          <units>ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="64.5" lower_limit="42.8" upper_limit="97.0"/>
                    <measurement group_id="O2" value="20.0" lower_limit="12.5" upper_limit="30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Major Adverse Cardiac Events</title>
        <description>Composite of death, myocardial infarction or repeat revascularization</description>
        <time_frame>30 days and 6 months</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Angiography-guided PCI</title>
            <description>Angiography-guided percutaneous coronary intervention</description>
          </group>
          <group group_id="O2">
            <title>IVUS-guided PCI</title>
            <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Major Adverse Cardiac Events</title>
          <description>Composite of death, myocardial infarction or repeat revascularization</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>30 days</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6-months</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Incidence of Contrast-induced Nephropathy</title>
        <description>Increase &gt;= 0.5 mg/dl in basal serum creatinine</description>
        <time_frame>7 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Angiography-guided PCI</title>
            <description>Angiography-guided percutaneous coronary intervention</description>
          </group>
          <group group_id="O2">
            <title>IVUS-guided PCI</title>
            <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Incidence of Contrast-induced Nephropathy</title>
          <description>Increase &gt;= 0.5 mg/dl in basal serum creatinine</description>
          <units>percentage of participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="42"/>
                <count group_id="O2" value="41"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19"/>
                    <measurement group_id="O2" value="7.3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>In-hospital</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Angiography-guided PCI</title>
          <description>Angiography-guided percutaneous coronary intervention</description>
        </group>
        <group group_id="E2">
          <title>IVUS-guided PCI</title>
          <description>Intravascular ultrasound guided percutaneous coronary intervention
IVUS-guided PCI: Intravascular ultrasound guided percutaneous coronary intervention</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Periprocedural Infarction</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="42"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Unplanned revascularization</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Stent Thrombosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="42"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Peak increase in creatinine &gt; 0.5mg/dl</sub_title>
                <description>Peak increase in creatinine &gt; 0.5mg/dl</description>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="42"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="41"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Patients were enrolled according to somewhat restricted criteria, which excluded patients with recent catheterization, using nephrotoxic agents, or with unstable or unknown renal function.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Pedro A. Lemos</name_or_title>
      <organization>Heart Institute (Incor)</organization>
      <phone>+55 11 2661 5000</phone>
      <email>pedro.lemos@incor.usp.br</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

